AMGN logo

Amgen (AMGN) EBIT

annual EBIT:

$7.76B-$2.97B(-27.64%)
December 31, 2024

Summary

  • As of today (April 18, 2025), AMGN annual earnings before interest & taxes is $7.76 billion, with the most recent change of -$2.97 billion (-27.64%) on December 31, 2024.
  • During the last 3 years, AMGN annual EBIT has fallen by -$134.00 million (-1.70%).
  • AMGN annual EBIT is now -29.01% below its all-time high of $10.94 billion, reached on December 31, 2018.

Performance

AMGN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNincome statement metrics

quarterly EBIT:

$1.53B-$2.35B(-60.56%)
December 31, 2024

Summary

  • As of today (April 18, 2025), AMGN quarterly earnings before interest & taxes is $1.53 billion, with the most recent change of -$2.35 billion (-60.56%) on December 31, 2024.
  • Over the past year, AMGN quarterly EBIT has dropped by -$144.00 million (-8.61%).
  • AMGN quarterly EBIT is now -61.63% below its all-time high of $3.98 billion, reached on March 31, 2023.

Performance

AMGN quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNincome statement metrics

TTM EBIT:

$7.76B-$144.00M(-1.82%)
December 31, 2024

Summary

  • As of today (April 18, 2025), AMGN TTM earnings before interest & taxes is $7.76 billion, with the most recent change of -$144.00 million (-1.82%) on December 31, 2024.
  • Over the past year, AMGN TTM EBIT has dropped by -$2.97 billion (-27.64%).
  • AMGN TTM EBIT is now -31.13% below its all-time high of $11.27 billion, reached on June 30, 2023.

Performance

AMGN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

AMGN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.6%-8.6%-27.6%
3 y3 years-1.7%-38.0%-1.7%
5 y5 years-25.5%-33.1%-23.4%

AMGN EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-27.6%at low-61.6%+102.3%-31.1%+15.2%
5 y5-year-27.6%at low-61.6%+102.3%-31.1%+15.2%
alltimeall time-29.0%>+9999.0%-61.6%+2160.7%-31.1%>+9999.0%

Amgen EBIT History

DateAnnualQuarterlyTTM
Dec 2024
$7.76B(-27.6%)
$1.53B(-60.6%)
$7.76B(-1.8%)
Sep 2024
-
$3.88B(+142.0%)
$7.91B(+17.4%)
Jun 2024
-
$1.60B(+111.9%)
$6.74B(-10.2%)
Mar 2024
-
$756.00M(-54.8%)
$7.50B(-30.1%)
Dec 2023
$10.73B(+22.6%)
$1.67B(-38.2%)
$10.73B(-4.4%)
Sep 2023
-
$2.71B(+14.4%)
$11.22B(-0.5%)
Jun 2023
-
$2.37B(-40.6%)
$11.27B(+4.7%)
Mar 2023
-
$3.98B(+84.2%)
$10.77B(+23.0%)
Dec 2022
$8.75B(+10.8%)
$2.16B(-21.6%)
$8.75B(-3.3%)
Sep 2022
-
$2.76B(+48.5%)
$9.05B(+3.5%)
Jun 2022
-
$1.86B(-5.6%)
$8.75B(+13.2%)
Mar 2022
-
$1.97B(-20.1%)
$7.73B(-2.2%)
Dec 2021
$7.90B(-15.9%)
$2.47B(+0.6%)
$7.90B(+3.6%)
Sep 2021
-
$2.45B(+192.1%)
$7.63B(-0.7%)
Jun 2021
-
$839.00M(-60.8%)
$7.68B(-16.2%)
Mar 2021
-
$2.14B(-2.4%)
$9.17B(-2.4%)
Dec 2020
$9.39B(-9.9%)
$2.19B(-12.5%)
$9.39B(-0.9%)
Sep 2020
-
$2.51B(+7.8%)
$9.48B(-0.9%)
Jun 2020
-
$2.33B(-1.7%)
$9.57B(-5.6%)
Mar 2020
-
$2.37B(+3.6%)
$10.14B(-2.8%)
Dec 2019
$10.43B(-4.7%)
$2.28B(-11.8%)
$10.43B(-2.4%)
Sep 2019
-
$2.59B(-10.6%)
$10.68B(+1.3%)
Jun 2019
-
$2.90B(+9.0%)
$10.54B(-0.9%)
Mar 2019
-
$2.66B(+4.7%)
$10.64B(-2.7%)
Dec 2018
$10.94B(+0.3%)
$2.54B(+3.6%)
$10.94B(-0.1%)
Sep 2018
-
$2.45B(-18.2%)
$10.95B(-2.3%)
Jun 2018
-
$2.99B(+1.3%)
$11.20B(+1.2%)
Mar 2018
-
$2.96B(+16.1%)
$11.07B(+1.6%)
Dec 2017
$10.90B(+4.6%)
$2.55B(-5.9%)
$10.90B(-0.6%)
Sep 2017
-
$2.71B(-5.5%)
$10.97B(-0.3%)
Jun 2017
-
$2.86B(+2.8%)
$11.00B(+3.2%)
Mar 2017
-
$2.79B(+6.7%)
$10.66B(+2.2%)
Dec 2016
$10.42B(+14.9%)
$2.61B(-4.8%)
$10.42B(+4.1%)
Sep 2016
-
$2.74B(+9.0%)
$10.01B(+2.8%)
Jun 2016
-
$2.52B(-1.4%)
$9.74B(+2.6%)
Mar 2016
-
$2.55B(+16.2%)
$9.50B(+4.7%)
Dec 2015
$9.07B(+36.3%)
$2.20B(-11.2%)
$9.07B(+7.7%)
Sep 2015
-
$2.47B(+8.8%)
$8.42B(+11.5%)
Jun 2015
-
$2.27B(+6.9%)
$7.55B(+3.2%)
Mar 2015
-
$2.13B(+37.6%)
$7.32B(+10.0%)
Dec 2014
$6.66B(+5.9%)
$1.55B(-3.7%)
$6.66B(+4.3%)
Sep 2014
-
$1.61B(-21.3%)
$6.38B(-2.4%)
Jun 2014
-
$2.04B(+39.4%)
$6.54B(+6.4%)
Mar 2014
-
$1.46B(+14.7%)
$6.14B(-2.3%)
Dec 2013
$6.29B(+3.7%)
$1.27B(-27.6%)
$6.29B(+1.0%)
Sep 2013
-
$1.76B(+6.9%)
$6.23B(+3.8%)
Jun 2013
-
$1.65B(+2.5%)
$6.00B(-1.1%)
Mar 2013
-
$1.61B(+32.3%)
$6.07B(+0.1%)
Dec 2012
$6.06B(+27.4%)
$1.21B(-20.9%)
$6.06B(-0.5%)
Sep 2012
-
$1.53B(-10.4%)
$6.09B(+17.8%)
Jun 2012
-
$1.71B(+7.0%)
$5.17B(+5.1%)
Mar 2012
-
$1.60B(+28.5%)
$4.92B(+3.4%)
Dec 2011
$4.76B(-19.6%)
$1.25B(+103.6%)
$4.76B(+1.8%)
Sep 2011
-
$612.00M(-58.1%)
$4.67B(-17.2%)
Jun 2011
-
$1.46B(+1.4%)
$5.65B(-2.6%)
Mar 2011
-
$1.44B(+24.1%)
$5.80B(-0.7%)
Dec 2010
$5.92B(+2.4%)
$1.16B(-26.7%)
$5.84B(-1.0%)
Sep 2010
-
$1.58B(-1.7%)
$5.89B(-1.6%)
Jun 2010
-
$1.61B(+8.8%)
$5.99B(+1.8%)
Mar 2010
-
$1.48B(+21.7%)
$5.88B(+1.8%)
Dec 2009
$5.78B(+3.9%)
$1.22B(-27.5%)
$5.78B(-4.5%)
Sep 2009
-
$1.68B(+11.4%)
$6.05B(+3.3%)
Jun 2009
-
$1.51B(+9.3%)
$5.86B(+5.9%)
Mar 2009
-
$1.38B(-7.4%)
$5.53B(-0.6%)
Dec 2008
$5.57B(+16.5%)
$1.49B(+0.4%)
$5.57B(+4.2%)
Sep 2008
-
$1.48B(+25.8%)
$5.34B(+10.3%)
Jun 2008
-
$1.18B(-16.7%)
$4.84B(+1.0%)
Mar 2008
-
$1.42B(+11.8%)
$4.79B(+0.3%)
Dec 2007
$4.78B(-5.8%)
$1.27B(+28.8%)
$4.78B(-16.6%)
Sep 2007
-
$983.00M(-13.0%)
$5.73B(-5.6%)
Jun 2007
-
$1.13B(-19.3%)
$6.07B(-4.2%)
Mar 2007
-
$1.40B(-36.9%)
$6.34B(+2.7%)
Dec 2006
$5.07B(+4.6%)
$2.22B(+67.9%)
$6.17B(+22.1%)
Sep 2006
-
$1.32B(-5.3%)
$5.05B(+0.5%)
Jun 2006
-
$1.40B(+13.1%)
$5.03B(+2.1%)
Mar 2006
-
$1.23B(+12.1%)
$4.93B(+1.6%)
Dec 2005
$4.85B(+24.2%)
$1.10B(-15.2%)
$4.85B(-7.1%)
Sep 2005
-
$1.30B(+0.4%)
$5.22B(+18.2%)
Jun 2005
-
$1.29B(+11.9%)
$4.42B(+6.9%)
Mar 2005
-
$1.16B(-21.5%)
$4.13B(+5.8%)
Dec 2004
$3.90B
$1.47B(+198.2%)
$3.90B(+22.6%)
Sep 2004
-
$494.00M(-50.9%)
$3.18B(-10.2%)
DateAnnualQuarterlyTTM
Jun 2004
-
$1.01B(+8.5%)
$3.55B(+5.7%)
Mar 2004
-
$928.00M(+22.9%)
$3.36B(+8.6%)
Dec 2003
$3.09B(+40.1%)
$755.00M(-11.9%)
$3.09B(+3.5%)
Sep 2003
-
$857.00M(+4.9%)
$2.99B(+12.1%)
Jun 2003
-
$817.10M(+23.4%)
$2.66B(+10.5%)
Mar 2003
-
$662.20M(+1.7%)
$2.41B(+9.3%)
Dec 2002
$2.21B(+44.1%)
$651.10M(+22.0%)
$2.21B(+25.0%)
Sep 2002
-
$533.70M(-5.5%)
$1.76B(+4.6%)
Jun 2002
-
$564.80M(+23.5%)
$1.69B(+7.3%)
Mar 2002
-
$457.40M(+118.7%)
$1.57B(+2.7%)
Dec 2001
$1.53B(+11.9%)
$209.10M(-54.2%)
$1.53B(-5.3%)
Sep 2001
-
$456.20M(+1.5%)
$1.62B(+4.4%)
Jun 2001
-
$449.40M(+7.9%)
$1.55B(+6.2%)
Mar 2001
-
$416.50M(+40.9%)
$1.46B(+3.4%)
Dec 2000
$1.37B(+3.3%)
$295.60M(-23.7%)
$1.41B(-2.4%)
Sep 2000
-
$387.60M(+8.2%)
$1.45B(+2.3%)
Jun 2000
-
$358.30M(-2.9%)
$1.41B(+1.5%)
Mar 2000
-
$368.90M(+11.6%)
$1.39B(+5.0%)
Dec 1999
$1.32B(+18.5%)
$330.60M(-7.0%)
$1.32B(+2.5%)
Sep 1999
-
$355.60M(+5.6%)
$1.29B(+5.1%)
Jun 1999
-
$336.80M(+11.5%)
$1.23B(+4.6%)
Mar 1999
-
$302.00M(+1.3%)
$1.18B(+5.1%)
Dec 1998
$1.12B(+20.2%)
$298.00M(+1.8%)
$1.12B(+7.2%)
Sep 1998
-
$292.80M(+3.5%)
$1.04B(+7.8%)
Jun 1998
-
$282.80M(+15.5%)
$967.70M(+2.5%)
Mar 1998
-
$244.80M(+9.9%)
$943.90M(+1.5%)
Dec 1997
$930.30M(+1.6%)
$222.80M(+2.5%)
$930.30M(-1.2%)
Sep 1997
-
$217.30M(-16.1%)
$942.00M(-1.8%)
Jun 1997
-
$259.00M(+12.0%)
$959.10M(+2.3%)
Mar 1997
-
$231.20M(-1.4%)
$937.90M(+4.1%)
Dec 1996
$916.00M(+20.4%)
$234.50M(+0.0%)
$901.10M(+3.9%)
Sep 1996
-
$234.40M(-1.4%)
$867.30M(+3.1%)
Jun 1996
-
$237.80M(+22.3%)
$841.00M(+5.4%)
Mar 1996
-
$194.40M(-3.1%)
$798.10M(+4.9%)
Dec 1995
$760.80M(+8.9%)
$200.70M(-3.6%)
$760.80M(+1.4%)
Sep 1995
-
$208.10M(+6.8%)
$750.40M(+3.3%)
Jun 1995
-
$194.90M(+24.1%)
$726.40M(+3.1%)
Mar 1995
-
$157.10M(-17.4%)
$704.50M(+0.8%)
Dec 1994
$698.50M(+26.7%)
$190.30M(+3.4%)
$698.60M(+8.1%)
Sep 1994
-
$184.10M(+6.4%)
$646.20M(+5.8%)
Jun 1994
-
$173.00M(+14.4%)
$610.90M(+5.8%)
Mar 1994
-
$151.20M(+9.6%)
$577.60M(+4.8%)
Dec 1993
$551.20M(+10.7%)
$137.90M(-7.3%)
$551.30M(-9.8%)
Sep 1993
-
$148.80M(+6.5%)
$611.50M(+5.2%)
Jun 1993
-
$139.70M(+11.8%)
$581.40M(+7.9%)
Mar 1993
-
$124.90M(-37.0%)
$538.60M(+8.1%)
Dec 1992
$498.10M(+303.6%)
$198.10M(+66.9%)
$498.10M(+30.4%)
Sep 1992
-
$118.70M(+22.5%)
$381.90M(+16.8%)
Jun 1992
-
$96.90M(+14.8%)
$326.90M(+109.8%)
Mar 1992
-
$84.40M(+3.1%)
$155.80M(+26.4%)
Dec 1991
$123.40M(+141.5%)
$81.90M(+28.6%)
$123.30M(+962.9%)
Sep 1991
-
$63.70M(-185.8%)
$11.60M(-131.8%)
Jun 1991
-
-$74.20M(-243.0%)
-$36.50M(-171.4%)
Mar 1991
-
$51.90M(-274.2%)
$51.10M(+421.4%)
Mar 1991
$51.10M(+75.6%)
-
-
Dec 1990
-
-$29.80M(-291.0%)
$9.80M(-80.9%)
Sep 1990
-
$15.60M(+16.4%)
$51.30M(+26.4%)
Jun 1990
-
$13.40M(+26.4%)
$40.60M(+40.5%)
Mar 1990
$29.10M(-706.3%)
$10.60M(-9.4%)
$28.90M(-164.9%)
Dec 1989
-
$11.70M(+138.8%)
-$44.50M(+27.5%)
Sep 1989
-
$4.90M(+188.2%)
-$34.90M(+71.1%)
Jun 1989
-
$1.70M(-102.7%)
-$20.40M(+325.0%)
Mar 1989
-$4.80M(-14.3%)
-$62.80M(-394.8%)
-$4.80M(-135.3%)
Dec 1988
-
$21.30M(+9.8%)
$13.60M(+130.5%)
Sep 1988
-
$19.40M(+12.1%)
$5.90M(-755.6%)
Jun 1988
-
$17.30M(-139.0%)
-$900.00K(-83.9%)
Mar 1988
-$5.60M(+300.0%)
-$44.40M(-426.5%)
-$5.60M(-132.7%)
Dec 1987
-
$13.60M(+7.9%)
$17.10M(+51.3%)
Sep 1987
-
$12.60M(0.0%)
$11.30M(+135.4%)
Jun 1987
-
$12.60M(-158.1%)
$4.80M(-469.2%)
Mar 1987
-$1.40M(+55.6%)
-$21.70M(-378.2%)
-$1.30M(-127.7%)
Dec 1986
-
$7.80M(+27.9%)
$4.70M(+135.0%)
Sep 1986
-
$6.10M(-6.2%)
$2.00M(-41.2%)
Jun 1986
-
$6.50M(-141.4%)
$3.40M(-950.0%)
Mar 1986
-$900.00K(-91.2%)
-$15.70M(-407.8%)
-$400.00K(-150.0%)
Dec 1985
-
$5.10M(-32.0%)
$800.00K(-129.6%)
Sep 1985
-
$7.50M(+177.8%)
-$2.70M(-69.0%)
Jun 1985
-
$2.70M(-118.6%)
-$8.70M(-17.1%)
Mar 1985
-$10.20M(+24.4%)
-$14.50M(-1006.3%)
-$10.50M(+66.7%)
Dec 1984
-
$1.60M(+6.7%)
-$6.30M(-20.3%)
Sep 1984
-
$1.50M(+66.7%)
-$7.90M(-16.0%)
Jun 1984
-
$900.00K(-108.7%)
-$9.40M(-8.7%)
Mar 1984
-$8.20M
-$10.30M
-$10.30M

FAQ

  • What is Amgen annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Amgen?
  • What is Amgen annual EBIT year-on-year change?
  • What is Amgen quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Amgen?
  • What is Amgen quarterly EBIT year-on-year change?
  • What is Amgen TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Amgen?
  • What is Amgen TTM EBIT year-on-year change?

What is Amgen annual earnings before interest & taxes?

The current annual EBIT of AMGN is $7.76B

What is the all time high annual EBIT for Amgen?

Amgen all-time high annual earnings before interest & taxes is $10.94B

What is Amgen annual EBIT year-on-year change?

Over the past year, AMGN annual earnings before interest & taxes has changed by -$2.97B (-27.64%)

What is Amgen quarterly earnings before interest & taxes?

The current quarterly EBIT of AMGN is $1.53B

What is the all time high quarterly EBIT for Amgen?

Amgen all-time high quarterly earnings before interest & taxes is $3.98B

What is Amgen quarterly EBIT year-on-year change?

Over the past year, AMGN quarterly earnings before interest & taxes has changed by -$144.00M (-8.61%)

What is Amgen TTM earnings before interest & taxes?

The current TTM EBIT of AMGN is $7.76B

What is the all time high TTM EBIT for Amgen?

Amgen all-time high TTM earnings before interest & taxes is $11.27B

What is Amgen TTM EBIT year-on-year change?

Over the past year, AMGN TTM earnings before interest & taxes has changed by -$2.97B (-27.64%)
On this page